Clinical Trials Browser

Phase 2 × Breast Cancer Metastatic × sacituzumab govitecan × Clear all

NCT06616987 2025-08-28

Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer

Phase 2 Recruiting

Breast Cancer Metastatic